The Patent Finder

Terms ending in 2036

Bayer Pharma Aktiengesellschaft

Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,316,001Method for Producing (4S)-4-[4-Cyano-2-(METHYLSULFONYL)PHENYL]-3,6-Dimethyl-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-Tetrahydro PYRIMIDINE-5-Carbonitrile
In force
 · High confidence
PH Pharma Co. Ltd.In forceHigh confidence
US 10,584,167ANTI-CEACAM6 Antibodies and Uses Thereof
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,866,495ANTI-CEACAM6 Antibodies and Uses Thereof
In force
 · Medium confidence
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen RechtsIn forceMedium confidence
US 10,137,209New Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 10,722,601Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 10,975,060High Relaxivity Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,491,245Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,814,369High Relaxivity Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · Low confidence
Bayer Pharma AktiengesellschaftIn forceLow confidence
US 12,478,696Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 10,435,403Positive Allosteric Modulators of Muscarinic M2 Receptor
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
18 more term ends in 2036 · Pro
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28.
Upgrade to Pro
26 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited